Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Jafna L, Cox"'
Autor:
Brittany Humphries, Jafna L Cox, Ratika Parkash, Lehana Thabane, Gary A Foster, James MacKillop, Joanna Nemis-White, Laura Hamilton, Antonio Ciaccia, Shurjeel H Choudhri, Bruno Kovic, Feng Xie
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background IMPACT-AF is a prospective, randomized, cluster design trial comparing atrial fibrillation (AF) management with a computerized decision support system (CDS) to usual care (control) in the primary care setting of Nova Scotia, Canad
Externí odkaz:
https://doaj.org/article/29522c5ae5a8490b8160e4a299c95922
Autor:
Arun Govindapillai, BHSc, MSc, PhD, Jafna L. Cox, MD, FRCPC, FACC, Lehana Thabane, PhD, Steve Doucette, MSc, Feng Xie, PhD, James H. MacKillop, PhD, Antonio Ciaccia, Shurjeel H. Choudhri, MD, Joanna M. Nemis-White, BSc, PMP, Laura M. Hamilton, Ratika Parkash, MD, MS, FRCPC
Publikováno v:
CJC Open, Vol 4, Iss 6, Pp 551-557 (2022)
Background: We examined the characteristics and outcomes in a contemporary ambulatory population of patients with atrial fibrillation (AF), comparing rate control with rhythm control. Methods: This is a post hoc analysis of a cluster-randomized trial
Externí odkaz:
https://doaj.org/article/6a98588ee2cc4232912412ed227d672e
Autor:
Joanna M. Nemis-White, Laura M. Hamilton, Sarah Shaw, James H. MacKillop, Ratika Parkash, Shurjeel H. Choudhri, Antonio Ciaccia, Feng Xie, Lehana Thabane, Jafna L. Cox, for the IMPACT-AF Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF) was a pragmatic, cluster randomized trial assessing the effectiveness of a clinical decision support (CDS) tool in primary care, Nova S
Externí odkaz:
https://doaj.org/article/568d4fc0a09644a6b6b5b4bbb3f9f45c
Autor:
Stephen B. Wilton, MD, MSc, Padma Kaul, PhD, Sunjidatul Islam, MBBS, MSc, Clare L. Atzema, MD, Jennifer Cruz, NP-Adult, MN, Kendra MacFarlane, MSc, Robert McKelvie, MD, PhD, Stephanie Poon, MD, Laurie Lambert, PhD, Kathy Rush, PhD, RN, Marc Deyell, MD, D. George Wyse, MD, PhD, Jafna L. Cox, MD, Allan Skanes, MD, Roopinder K. Sandhu, MD, MPH
Publikováno v:
CJC Open, Vol 3, Iss 5, Pp 609-618 (2021)
Background: Whether advances in identification and management of atrial fibrillation and atrial flutter (collectively, AF) have led to improved outcomes is unclear. We sought to study trends in clinical outcomes selected as quality indicators for non
Externí odkaz:
https://doaj.org/article/77a4549c52b54586ba0e0f6e8c1c024f
Autor:
John A. Queenan, PhD, Behrouz Ehsani-Moghaddam, PhD, Stephen B. Wilton, MD, MSc, Paul Dorian, MD, MSc, Jafna L. Cox, MD, Allan Skanes, MD, David Barber, MD, Roopinder K. Sandhu, MD, MPH
Publikováno v:
CJC Open, Vol 3, Iss 3, Pp 367-371 (2021)
Background: A recent feasibility assessment of quality indicators for nonvalvular atrial fibrillation/atrial flutter (NVAF/AFL) identified the Canadian Primary Care Sentinel Surveillance Network, a national outpatient electronic medical record (EMR)
Externí odkaz:
https://doaj.org/article/70796ac764a04a69b1130f61c274e279
Autor:
Joanna M. Nemis-White, Laura M. Hamilton, Sarah Shaw, James H. MacKillop, Ratika Parkash, Shurjeel H. Choudhri, Antonio Ciaccia, Feng Xie, Lehana Thabane, Jafna L. Cox, for the IMPACT-AF Investigators
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/b48190a2f011483398651627ccb2bd96
Autor:
Brittany Humphries, Jafna L. Cox, Ratika Parkash, Lehana Thabane, Gary A. Foster, James MacKillop, Joanna Nemis‐White, Laura Hamilton, Antonio Ciaccia, Shurjeel H. Choudhri, Feng Xie
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 15 (2021)
Background The IMPACT‐AF (Integrated Management Program Advancing Community Treatment of Atrial Fibrillation) trial is a prospective, randomized, cluster design trial comparing atrial fibrillation management with a computerized clinical decision su
Externí odkaz:
https://doaj.org/article/68718a6b5dd1424aa8659882a8979530
Autor:
Roopinder K. Sandhu, MD, MPH, Stephen B. Wilton, MD, MSc, Jennifer Cruz, NP-Adult, MN, Clare L. Aztema, MD, MSc, Kendra MacFarlane, MSc, Robert McKelvie, MD, PhD, Laurie Lambert, PhD, Kathy Rush, PhD, RN, Rodney Zimmerman, MD, Garth Oakes, PhD, Mark Deyell, MD, D. George Wyse, MD, PhD, Jafna L. Cox, MD, Allan Skanes, MD
Publikováno v:
CJC Open, Vol 1, Iss 4, Pp 198-205 (2019)
Background: In 2010, the Canadian Cardiovascular Society Atrial Fibrillation/Atrial Flutter (AF/AFL) quality indicator (QI) working group was established to develop QIs and assess feasibility of measurement. After extensive review, 3 priority QIs wer
Externí odkaz:
https://doaj.org/article/677eb7189a094b9aaa0fd594bd002b22
Autor:
Peter A. Kavsak, Lorna Clark, Saranya Arnoldo, Amy Lou, Jennifer L. Shea, Shaun Eintracht, Andrew W. Lyon, Vipin Bhayana, Laurel Thorlacius, Joshua E. Raizman, Albert K.Y. Tsui, Rose Djiana, Michael Chen, Yun Huang, Ronald A. Booth, Chris McCudden, Joël Lavoie, Daniel R. Beriault, David W. Blank, Angela W.S. Fung, Barry Hoffman, Jennifer Taher, Julie St-Cyr, Paul M. Yip, Emilie P. Belley-Cote, Beth L. Abramson, Bjug Borgundvaag, Steven M. Friedman, Susanna Mak, Jesse McLaren, Brian Steinhart, Jacob A. Udell, Harindra C. Wijeysundera, Paul Atkinson, Samuel G. Campbell, Kavish Chandra, Jafna L. Cox, Sharon Mulvagh, Ata-ur-Rehman Quraishi, Annabel Chen-Tournoux, Gregory Clark, Eli Segal, Neville Suskin, Amer M. Johri, Marco L.A. Sivilotti, Habibat Garuba, Venkatesh Thiruganasambandamoorthy, Simon Robinson, Frank Scheuermeyer, Karin H. Humphries, Martin Than, John W. Pickering, Andrew Worster, Nicholas L. Mills, P.J. Devereaux, Allan S. Jaffe
Publikováno v:
Kavsak, P A, Clark, L, Arnoldo, S, Lou, A, Shea, J L, Eintracht, S, Lyon, A W, Bhayana, V, Thorlacius, L, Raizman, J E, Tsui, A K Y, Djiana, R, Chen, M, Huang, Y, Booth, R A, Mccudden, C, Lavoie, J, Beriault, D R, Blank, D W, Fung, A W S, Hoffman, B, Taher, J, St-Cyr, J, Yip, P M, Belley-Cote, E P, Abramson, B L, Borgundvaag, B, Friedman, S M, Mak, S, Mclaren, J, Steinhart, B, Udell, J A, Wijeysundera, H C, Atkinson, P, Campbell, S G, Chandra, K, Cox, J L, Mulvagh, S, Quraishi, A, Chen-Tournoux, A, Clark, G, Segal, E, Suskin, N, Johri, A M, Sivilotti, M L A, Garuba, H, Thiruganasambandamoorthy, V, Robinson, S, Scheuermeyer, F, Humphries, K H, Than, M, Pickering, J W, Worster, A, Mills, N L, Devereaux, P J & Jaffe, A S 2023, ' Analytic result variation for high-sensitivity cardiac troponin: Interpretation and consequences ', Canadian journal of cardiology . https://doi.org/10.1016/j.cjca.2023.04.013
In a CODE-MI sub-study, six troponin assays were evaluated over 12 months using 3-samples (normal, female and male 99th-percentile levels; n=2,142 results from 67 instruments). Mean differences varied per assay with maximum values being ±4, ±8 and
Autor:
David Bewick, G.B. John Mancini, Philippe L. L’Allier, Derek So, Anil Gupta, Guillaume Marquis-Gravel, Todd J. Anderson, Shaun G. Goodman, Robert C. Welsh, Heather Kertland, Alan Bell, Simon Kouz, Ruth McPherson, Mina Madan, Graham C. Wong, Thao Huynh, Jean-Claude Tardif, Jean Grégoire, Jafna L. Cox
Publikováno v:
Canadian Journal of Cardiology. 37:1837-1845
A better understanding of the central role of inflammation in the development of coronary artery disease (CAD) has been the impetus for the evaluation of therapeutic strategies targeting the interleukin-1s/interleukin-6 cytokine signaling pathway, in